Federal Circuit Emphasizes Role of Filing Dates, Reversing Obviousness-Type Double Patenting InvalidationThe Federal Circuit reversed previous invalidity rulings on key pharmaceutical patents, emphasizing the significance of prosecution delays and patent term extensions.
Impact of Full Federal Circuit's Design Patent Decision is Far from ObviousThe 'flexible approach' in LKQ Corp. v. GM case may impact design patent validity challenges, potentially empowering challengers in arguing obviousness.